Literature DB >> 15549147

WHO-defined chronic neutrophilic leukemia: a long-term analysis of 12 cases and a critical review of the literature.

M A Elliott, C A Hanson, G W Dewald, S A Smoley, T L Lasho, A Tefferi.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15549147     DOI： 10.1038/sj.leu.2403562

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  30 in total

1.  T618I-Mutated Colony Stimulating Factor 3 Receptor in Chronic Neutrophilic Leukemia and Chronic Myelomonocytic Leukemia Patients who Underwent Allogeneic Stem Cell Transplantation.

Authors:  Sung-Eun Lee; Irene Jo; Woori Jang; Yonggoo Kim; Kyungja Han; Myungshin Kim
Journal:  Ann Lab Med       Date:  2015-04-01       Impact factor: 3.464

2.  Bleeding tendency in chronic neutrophilic leukemia.

Authors:  Toshio Shigekiyo; Junko Miyagi; Masahito Chohraku; Kazunori Kawauchi; Etsuko Sekimoto; Atsuhisa Shirakami; Hironobu Shibata
Journal:  Int J Hematol       Date:  2008-06-27       Impact factor: 2.490

3.  Ruxolitinib, a potent JAK1/JAK2 inhibitor, induces temporary reductions in the allelic burden of concurrent CSF3R mutations in chronic neutrophilic leukemia.

Authors:  Arief S Gunawan; Donal P McLornan; Bridget Wilkins; Katherine Waghorn; Yvette Hoade; Nicholas C P Cross; Claire N Harrison
Journal:  Haematologica       Date:  2017-03-16       Impact factor: 9.941

Review 4.  Epidemiology of MPN: what do we know?

Authors:  L A Anderson; M F McMullin
Journal:  Curr Hematol Malig Rep       Date:  2014-12       Impact factor: 3.952

5.  The SKI proto-oncogene enhances the in vivo repopulation of hematopoietic stem cells and causes myeloproliferative disease.

Authors:  Sofie Singbrant; Meaghan Wall; Jennifer Moody; Göran Karlsson; Alistair M Chalk; Brian Liddicoat; Megan R Russell; Carl R Walkley; Stefan Karlsson
Journal:  Haematologica       Date:  2014-01-10       Impact factor: 9.941

6.  B-lymphoblastic leukemia arising in a patient with chronic neutrophilic leukemia.

Authors:  Craig S Boddy; Brent T Tan; Joseph Aoki
Journal:  Blood Adv       Date:  2020-11-10

7.  Chronic neutrophilic leukaemia: an Egyptian case.

Authors:  Ashraf Elbahrawy; Mahmoud Hamdy; Mohamed Hanafy Morsy; Ramadan Ragab
Journal:  BMJ Case Rep       Date:  2009-06-24

8.  The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes.

Authors:  David P Steensma; Gordon W Dewald; Terra L Lasho; Heather L Powell; Rebecca F McClure; Ross L Levine; D Gary Gilliland; Ayalew Tefferi
Journal:  Blood       Date:  2005-04-28       Impact factor: 22.113

9.  Differential diagnostic challenge of chronic neutrophilic leukemia in a patient with prolonged leukocytosis.

Authors:  Daniel Neureiter; Ralf Kemmerling; Matthias Ocker; Christoph Seidlhofer; Viktoria Faber; Markus Stöcher; Richard Greil; Otto Dietze
Journal:  J Hematop       Date:  2008-04-19       Impact factor: 0.196

10.  CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia.

Authors:  A Pardanani; T L Lasho; R R Laborde; M Elliott; C A Hanson; R A Knudson; R P Ketterling; J E Maxson; J W Tyner; A Tefferi
Journal:  Leukemia       Date:  2013-04-22       Impact factor: 11.528
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.